Usage and Health Effects of Embodied Conversational Agents Among Older Adults

April 6, 2021 updated by: Lean Kramer, Wageningen University and Research

Rationale: Embodied Conversational Agents (ECAs), could be a highly effective medium to address health behaviour change among older adults. As compliance to health advice is important for positive health outcomes, successful design of persuasive ECAs can have huge health benefits. However, insights in the mechanisms underlying usage and health behaviour change via ECAs are lacking.

Objective: The objective is to unravel the mechanisms behind the use of an ECA intervention, and understand the mechanism behind the observed behaviour change

Study design: A randomized staggered-entry waitlist-controlled trial will be carried out.

Study population: The study population consist of Dutch-speaking older adults, who live independently, are without partner, are retired, 65+ and possess basic computer skills.

Intervention: The application PACO has been created for (and with) older adults with the goal to motivate them to improve their eating behaviour and decrease their feelings of loneliness.

Main study parameters/endpoints: The main study parameters are use, loneliness, and eating behaviour.

Nature and extent of the burden and risks associated with participation, benefit and group relatedness: Subjects are not exposed to any risks, nor have they any costs. They do have to fill in questionnaires and use the application. The duration and data collection moments are needed to gain a fine-grained understanding of the use, relationship development and health change process. For subjects, the main benefit is to gain insight in their health behaviour via the PACO-application. Although this might be experienced as confronting by some. The technology was developed based on sound theories, with input from the target group, so the investigators expect positive experiences and an improvement in participants loneliness and eating behaviour. However, this can only be proven after the study.

Study Overview

Study Type

Interventional

Enrollment (Actual)

52

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Gelderland
      • Wageningen, Gelderland, Netherlands, 6706 KN
        • Wageningen University & Research

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

63 years and older (Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Living independently at home
  • Living without a partner
  • No paid profession and at least 65 years of age
  • Dutch speaking
  • Able to use a tablet or computer
  • Internet connection at home

Exclusion Criteria:

  • Not willing to provide inform consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Sequential Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: PACO
Participants are asked to use the intervention for eight weeks.
The intervention is a fully-automated web-based eHealth application in which two embodied conversational agents engage in dialogue with older adults in order to motivate them towards dietary behavior change and decrease loneliness. The application consists of five different modules, each one applying different behavior change techniques.
Other: Waiting list + PACO
Participants receive the same intervention, but only after a waiting period of four weeks.
Waiting list + PACO

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Logdata on use application
Time Frame: 8 weeks
Amount of time spend on the application during the 8 weeks intervention period
8 weeks
Change in De Jong Gierveld Loneliness Scale
Time Frame: Four weeks before intervention to eight weeks
Score from 1-5, higher score means a better outcome.
Four weeks before intervention to eight weeks
Change in eating behaviour based on 24 hours recall
Time Frame: Four weeks before intervention to eight weeks
Four weeks before intervention to eight weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Enjoyment via affect scale
Time Frame: Eight weeks after intervention
Pleasure in using the application. Score from 1-5, higher score means a better outcome.
Eight weeks after intervention
Classic aesthetics Scale
Time Frame: Eight weeks after intervention
The design of the application. Score from 1-7, higher score means a better outcome.
Eight weeks after intervention
Concern for privacy scale
Time Frame: Four and eight weeks after intervention
Concerns about sharing personal data, e.g.name and date of birth. Score from 1-7, higher score means a better outcome.
Four and eight weeks after intervention
Active control scale
Time Frame: Eight weeks after intervention
Control over the system, as perceived by the user. Score from 1-7, higher score means a better outcome.
Eight weeks after intervention
System Usability Scale
Time Frame: Eight weeks after intervention
Whether PACO is easy to use. Score from 1-5, higher score means a better outcome.
Eight weeks after intervention
Perceived usefulness scale
Time Frame: Eight weeks after intervention
Score from 1-5, higher score means a better outcome.
Eight weeks after intervention
Rapport scale
Time Frame: Four weeks before intervention to eight weeks
Relationship with the embodied conversational agent. Score from 1-5, higher score means a better outcome.
Four weeks before intervention to eight weeks
Brief Older People's Quality of Life Scake
Time Frame: Four weeks before intervention to eight weeks
Score from 1-5, higher score means a better outcome.
Four weeks before intervention to eight weeks
Change in Basic Psychological Need Satisfaction and Frustration Scales
Time Frame: Four weeks before intervention to eight weeks
Score from 1-5, higher score means a better outcome.
Four weeks before intervention to eight weeks

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Willingness to pay single questions
Time Frame: Eight weeks after intervention
Willing to pay for PACO (y/n)
Eight weeks after intervention
User experience via self-formulated open question
Time Frame: Four and eight weeks after intervention
Four and eight weeks after intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 13, 2020

Primary Completion (Actual)

December 30, 2020

Study Completion (Actual)

December 30, 2020

Study Registration Dates

First Submitted

July 13, 2020

First Submitted That Met QC Criteria

August 11, 2020

First Posted (Actual)

August 12, 2020

Study Record Updates

Last Update Posted (Actual)

April 8, 2021

Last Update Submitted That Met QC Criteria

April 6, 2021

Last Verified

April 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • 40-44300-98-110

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Yes

IPD Plan Description

In accordance with the Data Management Plan, part of the data will be anonymized and made available in DANS-EASY with restricted access.

IPD Sharing Time Frame

The data will become available within 12 months after the end of the study.

IPD Sharing Supporting Information Type

  • Study Protocol
  • Statistical Analysis Plan (SAP)
  • Informed Consent Form (ICF)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Loneliness

Clinical Trials on PACO

3
Subscribe